Zanamivir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk No edit summary |
imported>David E. Volk mNo edit summary |
||
| Line 14: | Line 14: | ||
== External links == | == External links == | ||
* {{DailyMed} | * {{DailyMed}} | ||
* Drug Bank at http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB00558.txt | * Drug Bank at http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB00558.txt | ||
Revision as of 13:48, 3 February 2008
Zanamivir is a guanido-neuraminic acid that is a neuraminidase inhibitor used as an antiviral drug to treat influenza A and B.
Its IUPAC chemical name is (4S,5R,6R)-5-acetamido-4-(diaminomethylideneamino)-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid and its chemical formula is C12H20N4O7.
Brand names
- GANA
- GNA
- Relenza (GlaxoSmithKline)
- ZMR
- Zanamavir
External links
- Zanamivir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Drug Bank at http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=DB00558.txt